Adynxx Stock to Move to OTC Market Following Receipt of Nasdaq Delisting Notice

World News: . []

SAN FRANCISCO June 12 2019 GLOBE NEWSWIRE -- AdynxxIncNasdaq ADYX a clinical-stage biopharmaceutical companyleadingthe development oftranscription LINK  decoy technology and first-in-class therapeuticsfor the treatment ofp ain and...

More news and information about Adynxx, Inc.

Published By:

Globe Newswire: 17:32 GMT Wednesday 12th June 2019

Published: .

Search for other references to "adynxx" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us